QBFM
VRTX icon

QS Batterymarch Financial Management’s Vertex Pharmaceuticals VRTX Stock Holding History

QS Batterymarch Financial Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$326K Hold
2,900
– – 0.01% 627
2014
Q2 		$275K Sell
2,900
-21,470
-88% -$1.51M 0.01% 649
2014
Q1 		$1.72M Sell
24,370
-209
-0.9% -$16.6K 0.04% 544
2013
Q4 		$1.83M Sell
24,579
-120
-0.5% -$8.36K 0.04% 507
2013
Q3 		$1.87M Buy
+24,699
New +$1.97M 0.04% 499

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

QS Batterymarch Financial Management's VRTX Position: Q3 2014 in Review

QS Batterymarch Financial Management held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2014 at 2,900 shares worth $326K. The position accounts for 0.01% of the portfolio, ranked #627.

QS Batterymarch Financial Management first reported a position in VRTX in Q3 2013 and has held it in 5 quarters since. The position peaked at $1.87M in Q3 2013. 431 funds tracked by Wall St. Rank hold VRTX as of Q3 2014.

  • QS Batterymarch Financial Management held 2,900 shares of Vertex Pharmaceuticals worth $326K as of Q3 2014.
  • QS Batterymarch Financial Management left its Vertex Pharmaceuticals share count unchanged in Q3 2014.
  • Vertex Pharmaceuticals made up 0.01% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #627 holding.
  • QS Batterymarch Financial Management first reported a position in Vertex Pharmaceuticals in Q3 2013 and has held it in 5 quarters since.
  • QS Batterymarch Financial Management's Vertex Pharmaceuticals position peaked at $1.87M in Q3 2013.
  • 431 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.